SPINK1 Produkte
(serine Peptidase Inhibitor, Kazal Type 1 (SPINK1))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte SPINK1 Kategorien
SPINK1 Antikörper
High quality antibodies with extensive validation data.
SPINK1 ELISA Kits
Reliable ELISA kits for a wide range of species.
SPINK1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene SPINK1 Antikörper
- (8)
- (5)
- (3)
- (3)
Empfohlene SPINK1 ELISA Kits
- (2)
- (1)
- (1)
- (1)
Empfohlene SPINK1 Proteine
- (1)
- (1)
- (1)
Neueste Publikationen zu unseren SPINK1 Produkten
: "Surgical decompression of Wirsung duct reduces serum concentration of SPINK1 in patients with chronic pancreatitis." in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], Vol. 18, Issue 3, pp. 275-279, (2018) (PubMed).: "Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers." in: Oncotarget, Vol. 6, Issue 34, pp. 35737-54, (2016) (PubMed).
: "Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial." in: Urologic oncology, Vol. 33, Issue 3, pp. 108.e5-108.e13, (2015) (PubMed).
: "Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India." in: The Prostate, Vol. 75, Issue 10, pp. 1051-62, (2015) (PubMed).
: "The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line." in: Tumour biology, (2015) (PubMed).
: "A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer." in: Tumour biology, Vol. 35, Issue 3, pp. 2759-67, (2014) (PubMed).
: "HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey." in: The American journal of surgical pathology, Vol. 38, Issue 5, pp. 615-26, (2014) (PubMed).
: "Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer." in: The Prostate, Vol. 74, Issue 7, pp. 689-701, (2014) (PubMed).
: "Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy." in: Urologic oncology, Vol. 31, Issue 8, pp. 1716-24, (2013) (PubMed).
: "Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 26, Issue 6, pp. 835-48, (2013) (PubMed).
Synonyme und alternative Namen zu SPINK1
serine peptidase inhibitor, Kazal type 1 (SPINK1), serine peptidase inhibitor, Kazal type 1 (Spink1), p12, PCTT, PSTI, Psti, SPINK1, Spink3, TATI, TCPBezeichner auf Proteinebene für SPINK1
- pancreatic secretory trypsin inhibitor
- serine protease inhibitor Kazal-type 1
- serine protease inhibitor, Kazal type 1
- tumor-associated trypsin inhibitor
- PSTI-II
- calcium transport inhibitor
- caltrin
- pancreatic secretory trypsin inhibitor II
- pancreatic secretory trypsin inhibitor type II (PSTI-II)
- serine peptidase inhibitor, Kazal type 3
- serine protease inhibitor Kazal-type 3
- serine protease inhibitor, Kazal type 3
- serine peptidase inhibitor, Kazal type 1
- prostatic secretory glycoprotein